Table 2.
Study Design Issues Identified During Trial Planning and Types of Adaptive Designs to Potentially Address These Issues
| Study Design Issue Identified in Trial Planning | Adaptive Design to Potentially Address the Issuea |
|---|---|
| Imprecise estimate of control group response rate or variation in responses | Sample size adjustment |
| Imprecise magnitude and/or precision of effect size | Sample size adjustment Predicted intervals |
| Uncertainty regarding subjects most likely to experience a benefit or a toxicity | Population enrichment |
| Uncertainty regarding the optimal dose of a new drug to assess its efficacy | Seamless phase II/III trial; multiarm, multistage trial |
| Multiple drugs, drug combinations, or treatment or testing strategies need to be evaluated in a consistent and efficient manner | Multiarm, multistage trial; platform trial |
| Uncommon or rare condition makes it difficult to recruit sufficient subjects | Umbrella or basket trial |
| Uncertainty or evolution in optimal end point(s) to evaluate efficacy or safety | Changing end points |
aSee text for discussion of the advantages and limitations of specific designs.